Newborn Screening Market Size

Newborn Screening Market Size

Newborn Screening Market size was valued at around USD 950.5 million in 2023 and is estimated to grow at 7.7% CAGR from 2024 to 2032. Newborn screening is a systematic public health program that involves testing newborn infants for certain genetic, metabolic, and congenital disorders shortly after birth.

To get key market trends

  Download Free Sample

The primary objective of newborn screening is to detect conditions that may not be immediately apparent but have the potential to cause serious health issues if left untreated. As per statistics, the global birth rate in 2023 stood at 17.46 births per 1000 individuals. Consequently, a rise in childbirth rates is expected to yield a favorable impact on the market.

Furthermore, the expansion of newborn screening panels represents a strategic shift towards a more inclusive and detailed assessment of a newborn's health. This initiative involves screening of conditions that occurs in the early stages of life, with a particular focus on rare diseases, metabolic disorders, and genetic abnormalities. This expansion aims to create more comprehensive screening panels that can detect a broader range of potential health concerns in early infancy, fuelling its increasing demand in the healthcare industry.